Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC

Clinical trial NCT07718243 · RECRUITING

Trial details

NCT number: NCT07718243
Sponsor: Institute of Cancer Research, United Kingdom
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin Cancer)Non Small Cell Lung Cancer Solid Tumor in Advanced Stage

Start date: 2026-08-01
Primary completion: 2030-01-31
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.